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Introduction
HIV infection may be associated with different arthropathies 
that are often underdiagnosed.[1-8] These articular 
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Abstract
Background: HIV infection may be associated with different arthropathies that are often 
underdiagnosed. There is also paucity of reported studies of relationship between clinical and 
laboratory features of HIV‑infected patients and articular disorders. Aims: To determine 
the predictors of articular disorders among HIV‑infected patients seen at tertiary hospital 
Nigeria. Subjects and Methods: Hospital‑based cross‑sectional descriptive study. Subjects 
were recruited from outpatient clinics of the study centers. Persons aged 16 years and 
above were recruited via stratified sampling method. Subjects with trauma, degenerative 
arthritis, malignancy, hepatitis B surface antigen and anti‑hepatitis C virus positivity or 
previously known to have pulmonary tuberculosis or rheumatological disorders were excluded. 
Pretest‑improved semi‑structured questionnaire was administered to the recruited 480 
subjects comprising 240 HIV positive subjects (HPS) and 240 HIV‑negative subjects (HNS). 
Blood for relevant laboratory tests and radiographs were done where necessary. Diagnosis 
of articular disorder was based on American College of Rheumatology and European 
Spondyloarthropathy Study Group classification guidelines. Statistical Package for Social 
Sciences version 15 (SPSS Inc., Chicago, IL, USA) was used for data entry, validation, and 
analysis. Results: Of the 480 participants, both HPS and HNS were made up of 95 males 
and 145 females. There was statistically significant difference between the frequency of 
occurrence of articular disorders among the HPS of 37.1% (89/240)  and the HIV‑negative 
controls of 16.2% (39/240) (2 = 26.63 P = <0.01). Arthralgia frequency of 29.6% (71/240), 
HIV‑associated arthritis 4.6%, (11/240) (Reiter’s disease 1.3% (3/240), undifferentiated 
spondyloarthropathy 1.3%, (3/240) and gout 0.4% (1/240) (were seen among the HPS. Only 
arthralgia was found among HNS. Erythrocyte sedimentation rate (ESR) and age were the 
best predictors of arthralgia presence. CD4+ T‑cell count was predictive of HIV‑associated 
arthritis. Conclusions: Articular disorders are commoner among HIV patients than HNS. 
ESR and age were the best predictors of Arthralgia presence among HIV‑infected patients. 
CD4+ T‑cell count was predictive of HIV‑associated arthritis.
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conditions (arthralgia, arthritis, and spondyloarthropathy) are 
either caused by the HIV infection itself, antiretroviral therapy, 
adaptive changes in the immune system or are secondary to 
microbial infections. There is paucity of reported studies of 
articular disorders among HIV-positive subjects (HPS) in 
Nigeria. There is also paucity of reported studies of relationship 
between clinical and laboratory features of HIV-infected 
patients and articular disorders. This study was embarked 
on to determine the predictors of articular disorders among 
HIV-infected patients seen at a tertiary institution in South 
East Nigeria.
Hypothesis
The erythrocyte sedimentation rate (ESR), duration of highly 
active antiretroviral therapy (HAART), age, CD4+ T-cell 
count, and viral load of the HPS are predictors of articular 
disorders among HPS.
Subjects and Methods
The study was a hospital based cross-sectional descriptive 
study. It was conducted at a Tertiary Health Institution in 
South East Nigeria. The HPS were recruited from the GOPD 
and special HIV clinics of the study center, and the controls 
from the Voluntary Confidential Counseling and Testing 
Centers. The recruitment of subjects for the study took place 
from August 3, 2011 to May 28, 2012. The study population 
was largely Igbo tribe. Ethical approval was obtained from 
the Ethics and Research Committee of the Tertiary Health 
Institution. Also, permission to use the HIV laboratory 
services and data repository was sought and obtained from 
the Harvard School of Public Health (President’s Emergency 
Plan for AIDS Relief) Boston USA (The sponsor of the HIV/
ARV Clinic). The provisions of Helsinki Declaration were 
observed.
The sample size (n) was determined using the WHO formula[9] 
for calculating the minimum sample size from an infinite 
population and prevalence rate of articular disorders among 
HIV patients in Kenya of 17%.[10] Thus n = 216 rounding up 
by 10%, for higher accuracy appropriate sample size = 240 
HPS. The control was: 240 HIV-negative subjects (HNS). 
These gave a total of 480 subjects for the study.
Subjects were recruited by systematic random sampling of all 
the HPS attending the clinics of the tertiary health institution 
hospitals. Every third HPS attending the clinics was recruited 
if he or she was eligible and gave consent. Those that were not 
eligible or declined consent were dropped and the systematic 
sampling continued until the sample size was completed. The 
HPS was matched gender and age group wise with the control. 
A pretest questionnaire was administered to 30 HIV-positive 
and 30 HIV-negative subjects who were recruited randomly 
from the eligible participants to assess performance and 
applicability of the semi-structured questionnaire for detection 
of articular disorders. Observations made were used to improve 
on the semi-structured questionnaire, but the subjects for the 
pretest were however excluded from the main study.
The pretest-improved semi-structured researcher administered 
questionnaire was applied to the study population. It was used 
to assess the symptoms and the signs of articular disorders 
and tests results. The researcher administered questionnaire had 
sections containing examination based on the gait, arms, spine, 
and legs (GALS) locomotor screen. Those with abnormal 
GALS screen were further interviewed and examined as per the 
American College of Rheumatology (ACR) ad hoc committee 
on clinical guidelines for the initial evaluation of adults with 
acute musculoskeletal symptoms.[11]
Blood samples were drawn for ESR, viral loads and 
CD4+ T-lymphocyte cell count determination. HIV positivity 
was confirmed either by double ELISA (strip and micro‑pit) or 
ELISA and Western blot. Patients with inflammatory arthritis 
additionally did serum uric acid, rheumatoid factor (RF) 
and antinuclear antibody tests (ANA). RF was done by 
latex agglutination test, and ANA tests were done by ELISA 
method. Standard digital radiographs of affected joints were 
taken in indicated subjects. Patients with hip and alternating 
buttock pains had plain radiography of both hips and sacroiliac 
joints (anteroposterior view) which were evaluated by same 
radiologist for features of avascular necrosis (AVN) and 
sacroiliitis, respectively. Synovial fluid was obtained, for 
analysis and microscopy, culture/sensitivity testing and 
acid fast bacilli detection in those with demonstrable joint 
effusion. The clinically evident articular features, laboratory, 
and radiographic findings were used to reach diagnosis 
of articular disorder. The diagnosis and classification 
for rheumatic articular disorders were based on ACR 
classification guidelines for these articular disorders[4,12,13] but 
on European Spondyloarthropathy Study Group (ESSG) for 
spondyloarthropathy.[14]
Statistical Package for Social Sciences 15 version (SPSS Inc., 
Chicago, IL, USA) was used for data entry, validation, and 
analysis.
Results
A total of 480 participants were recruited for the study 
comprising 240 HPS as test subjects and 240 HNS as control 
subjects. Both HPS and HNS were made up of 95 males and 
145 females. The mean age of the HPS was 38.1 (10.2) years 
and ranged from 17 to 61 years. The controls had a mean 
age of 38.4 (10.5) years and ranged from 16 to 63 years. As 
expected, there was no statistically significant difference 
between the mean age of the HPS 38.1 (10.2) years and control 
38.4 (10.5) years (t = 0.305, P = 0.76). Table 1a and b shows 
the age group distribution and the sociodemographics of the 
study population respectively.
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Occupational distribution and marital status of 
respondents
They are shown in Table 2. Across all articular disorder groups, 
artisans were the most frequently afflicted occupational group.
Viral load, CD4+ T‑cell count and erythrocyte 
sedimentation rate of the study population
The mean viral load of the 240 HPS was 133,697.36 (315,732.5) 
copies/μl. The median viral load was 5488.5 copies/μl. The 
Mann–Whitney U-test showed that the ranked mean (146.5) 
of the viral load of HIV-positive HAART naïve subjects was 
significantly higher than that (94.50) of HIV‑positive HAART 
exposed subjects (U = 4080.5, P = <0.01).
The mean CD4+ T-lymphocyte cell count of HPS and controls 
were respectively 326.57 (240.7) cells/μl and 951.35 (332.3)/μl, 
while the median CD4+ T-lymphocyte cell count of HPS and 
controls were 234.0/μl and 864.0/μl, respectively.
The mean ESR of HPS was 67.0 (42.4) mm 1st h while that 
of HNS was 15.0 (10.7) mm 1st h. There was statistically 
significant difference between the mean ESR of the HPS 
and HNS (t = 18.41, P < 0.01). Figure 1 shows the box plot 
graph of CD4+ T-cell count, articular disorder, and HIV 
status of the study population. From the Figure 2, it is clear 
that the viral loads for both HPS with arthralgia and without 
arthralgia were similar while the CD4+ T-cell counts were 
higher for HPS without articular disorders than the HPS with 
articular disorders. Figure 2 shows viral load, Arthralgia, and 
CD4+ T-cell counts of HIV-infected subjects. Figure 3 shows 
box plot of ESR, articular disorder, and HIV status of the 
study population.
Highly active antiretroviral therapy and study 
population
One hundred and twenty of the 240 HPS (i.e., half) were on 
HAART.
Articular disorder diagnosis among HIV positive cases 
and controls
The frequency of all articular disorders in the population of 
HPS was 37.1% (89/240) while that among the control was 
16.2% (39/240). There was statistically significant difference 
between the frequency of occurrence of articular disorders 
among the HPS and the controls (2 = 26.63 P = <0.01). The 
frequencies of the different articular disorders found among the 
HPS are as follows: Arthralgia (29.6%, 71/240), HIVAA (4.6%, 
11/240), Reiter’s disease (1.3%, 3/240), undifferentiated 
spondyloarthropathy (1.3%, 3/240), and gout (0.4%, 1/240). 
Only arthralgia was found among HNS.
The characteristics of the subjects and that of the articular 
disorders (arthralgia and HIVAA) are shown in Tables 1-3.
Predicators of arthralgia, HIV‑associated arthritis, 
spondyloarthropathy and Reiter’s disease among 
HIV‑positive subjects
The backward logistic regression analysis of the hypothesized 
factors that predict arthralgia among HPS was done. The ESR, 
duration of HAART, age, CD4+ T-cell count, and viral load of 
Figure 1: CD4+ T lymphocyte count, HIV status, and articular disorder 
of the study population
Table 1a: Age group distribution of study population
Age 
group
Study population N (%) Total 
N (%)Test Control
10‑19 7 (2.9) 7 (2.9) 14 (2.9)
20‑29 37 (15.4) 37 (15.4) 74 (15.4)
30‑39 98 (40.8) 98 (40.8) 196 (40.8)
40‑49 58 (24.2) 58 (24.2) 116 (24.2)
50‑59 34 (14.2) 34 (14.2) 68 (14.2)
60‑69 6 (2.5) 6 (2.5) 12 (2.5)
Total 240 (100.0) 240 (100.0) 480 (100.0)
Table 1b: The socio‑demographic features of the study 
population
Variable HIV+ HIV−
N % N %
Occupational distribution
Unemployed 15 6.3 9 3.8
Artisans 81 33.8 77 32.1
Student 16 6.7 23 9.6
Professional 36 15 33 13.6
Trader 67 27.8 71 29.6
Farmer 25 10.4 27 11.3
Marital status
Single 177 73.8 158 65.8
Married 57 23.8 60 25.0
Divorced 6 2.5
Co‑habiting 0 0 11 4.6
Separated 0 0 10 4.2
Widow (er) 0 0 1 0.4
HIV: Human Immunodeficiency Virus
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the HPS were entered. ESR and age were the best predictors 
of arthralgia presence (OR = 1.018, P = <0.01 for ESR) 
and (OR = 1.035, P = 0.024 for age). For every 2-fold increase 
in ESR, arthralgia is 101 times more likely to be present than 
absent. For every 3-fold increase in age, arthralgia is 103 times 
more likely to be present than absent. Again looking at the 
contribution of each of the two variables with the other kept 
constant, 27.64% of the explained arthralgia variance was by 
ESR while only 5.25% by age. The overall specificity of this 
prediction was 71.7% that is quite good.
Figure 2: Viral load CD4+ T‑cell count and presence of arthralgia of 
the study population
Figure 3: Erythrocyte sedimentation rate, presence of articular disorder 
and HIV status of study population
Table 2a: The characteristics of HIV infected subjects with Arthralgia and HIV negative subjects with Arthralgia
Variable HIV positive N Percent HIV negative N Percent
Age group
10‑19 1 1.4 0 0
20‑29 8 11.3 4 10.3
30‑39 30 42.3 10 25.6
40‑49 18 25.4 13 33.3
50‑59 11 15.5 10 25.6
60‑69 3 4.2 2 5.1
Marital status
Single 56 78.9 23 59
Married 10 14.1 10 25.6
Divorced 5 7.0 0 0
Co‑habiting 0 0 1 2.6
Separated 0 0 4 10.3
Widow(er) 0 0 1 2.6
Occupation
Unemployed 2 2.8 0 0
Artisan 23 32.4 13 33.3
Student 2 2.8 2 5.1
Professional 16 22.5 6 15.4
Trader 16 22.5 7 17.9






Tenofovir, emtricitabine and Nevirapine 4 5.6
Tenofovir, emtricitabine and Efavirenz 4 5.6
Efavirenz, lamivudine and Abacavir 1 1.4
Zidovuldine, lamivudine and Nevirapine 26 36.
HIV: Human Immunodeficiency Virus
Okwara, et al.: Predictors of articular disorders among HIV‑Infected patients
Annals of Medical and Health Sciences Research | Nov-Dec 2015 | Vol 5 | Issue 6 | 451
The logistic regression analysis of hypothesized factors that 
predict HIVAA among HPS was done with CD4+ T-cell count, 
ESR, age, viral loads, and HIV disease duration entered into 
the equation initially. The result shows that only CD4+ T-cell 
count was predictive of HIVAA (OR = 0.994, P = 0.01). For 
every 6-fold decrease in CD4 T-cell count, HIVAA is 994 times 
more likely to be present than absent.
The logistic regression analysis of hypothesized factors 
that predict undifferentiated spondyloarthropathy, Reiter’s 
disease among HPS was done with CD4+ T-cell count, ESR, 
Age, viral loads, and HIV disease duration entered into the 
equation initially. The result shows that none was predictive 
of undifferentiated spondyloarthropathy, Reiter’s disease 
(P > 0.05 in all).
Discussion
Articular disorders are frequent but often under-diagnosed 
manifestation in patients infected with HIV.[1-8] The prevalence of 
articular disorders in HPS has been reported to be 4.6–70%.[4-8,10] 
The reported range is wide and reflects prevalence from 
different regions of the globe and can be explained by 
differences in definitions, in populations characteristics, and 
in environments. In Nigeria, Adelewo et al. reported five cases 
to illustrate the spectrum of rheumatological manifestations 
of HIV among Nigerians.[15] In other parts of Africa and 
globally, available reports are on the rate of positivity to HIV 
antibodies among patients with certain articular disorders.[16,17] 
This study has added further statistics to the available studies 
and case reports on articular disorders among HIV-infected 
persons.[5,6,8,10,13-18] The prevalence of articular disorders in 
HPS of 37.1% found in this study is in keeping with previous 
reports of 4.6–70%.[2,4-8,10,13] The significantly higher prevalence 
compared to controls suggested that HIV infection may be 
associated with articular disorders. The prevalence got in 
this study may be close to the true value because the subjects 
recruited for this prospective study were evaluated and 
classified based on ESSG and ACR classification guidelines 
for these articular disorders. Again viral infection like hepatitis 
viruses C and B were excluded during recruitment of subjects.
Table 2b: Characteristics of HIV positive subjects with 
Arthralgia
Variable N Percent
Complaint at HIV screening 
Others 51 71.8
Joint pain + others 17 23.9




















Class I 9 12.7
Class II 58 81.7
Class III 4 5.6
Class IV 0 0
WHO HIV disease stage
State 1 1 1.4
State 2 60 84.5
State 3 10 14.1
HIV: Human Immunodeficiency Virus














Presenting complaint at HIV screening test
Arthritis 1 9.1
Others 7 63.6











Class 2 7 63.6
Class 3 4 36.4
WHO HIV disease stage
Stage 2 3 27.3
Stage 3 8 72.7
HIV: Human Immunodeficiency Virus
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The similarity of the overall occupational distributions of 
the HPS and controls reflect the occupational distribution 
of residents of Enugu. Across all articular disorder groups, 
Artisans were the most frequently afflicted occupational group. 
This is worrisome because being artisans they needed their 
joints to be functionally optional. The increased joint problem 
among these artisans with HIV infection predisposes them to 
functional impairment and decreased productivity thereby 
deepening the burden that HIV infections had put on them.
The articular disorder types among HIV‑positive and 
HIV‑negative subjects
The articular disorders reported among HPS include 
Reiter’s syndrome, HIV-associated arthritis, painful articular 
syndrome, acute symmetric polyarthritis, undifferentiated 
spondyloarthropathy, AVN of bone heads, septic arthritis, 
arthralgia, psoriatic arthritis, and gout. The control population 
also have articular disorders reportedly including any form 
of articular disorder including inflammatory, infective, 
degenerative, and neoplastic articular disorders.
The design of this study excluded the articular disorders that 
are degenerative, neoplastic or related to medications other 
than HAART. Thus persons with osteoarthritis, tuberculostatic 
medications, medications with hyperuricemia adverse effects, 
malignancies were not recruited as subjects.
The HPS in this study was found to have only arthralgia, 
HIV-associated arthritis, Reiter ’s disease, gout and 
undifferentiated spondyloarthropathy. None had painful 
articular syndrome, acute symmetric polyarthritis, AVN of 
head of bone, septic arthritis, and psoriatic arthritis.
The absence of painful articular syndrome and acute symmetric 
polyarthritis may be explained by the fact that their prevalence 
was very low among the HPS in Enugu to be picked in the 
course of the cross-sectional study or that the HPS in the 
recruitment area Enugu do not have these articular disorder 
types. Their being acute and transient articular disorders may 
have made their prevalence to be very low and thus not found 
within the study population and period.
The absence of AVN of head bone and psoriatic arthritis may 
be a characteristic of HPS in the areas of recruitment. For 
the AVN, the recruited subjects had HIV infection, half were 
on HAART but median/mean CD4+ T-cell count were well 
above 60/μl. The HIV positivity and percentage of them on 
HAART were among the reported risk factors for AVN.[19] But 
CD4+ T-cell count less 60/μl was reported as a risk factor for 
development of AVN of head of bone.[19]
The absence of septic arthritis is interesting. Septic arthritis was 
thought to be expectedly high among HPS. However, overtime 
this has proved to be untrue. There has not been demonstration 
of any clear relationship between CD4 count and septic 
arthritis.[20] In fact, HIV predisposing to septic arthritis has 
been disputed.[20] It is rather increasingly thought to be related 
to simultaneous intravenous drug abuse. This era of increased 
HIV awareness, better health seeking behavior of HIV-infected 
subjects, early diagnosis, HAART and availability of more 
potent antibiotics may be the explanation for the absence of 
septic arthritis among the HPS studied. Moreover, intravenous 
drug abuse is not common in Enugu Nigeria.
For the HNS, the articular disorder found among them was 
arthralgia. Exclusion criteria eliminated most of the other 
articular disorders (osteoarthritis, malignant arthropathies, 
trauma, etc.) that could be seen among the subjects.
Predictors of articular disorders among HIV subjects
The ESR and age of HPS were both found to be predictive of 
Arthralgia. Every 2-fold increase in ESR value was predictive 
of 101 times likelihood of arthralgia presence than arthralgia 
absence while increase 3-fold in age was required for 103 
likelihood of arthralgia presence than absence suggesting 
that ESR of the subjects was a better predictor of arthralgia 
presence than age. ESR is a marker of systemic inflammation, 
hence higher ESR values, indicating widespread systemic 
inflammation may explain the significantly higher frequency 
of arthralgia with higher ESR values. It also explains partly the 
predictability of arthralgia incidence with higher ESR. For the 
age, older age goes with same immune dysregulation which is 
worse in the HIV-infected persons. The contribution of age to 
prediction as shown in the result is small; however the immune 
dysregulation and the wear and tear that goes with aging may 
be the explanation for increasing frequency/predictability of 
arthralgia with advancing age.
The logistic regression strongly suggested that ESR, age, viral 
loads, and CD4+ T-lymphocyte count have no relationship 
with Reiter’s disease and undifferentiated spondyloarthropathy 
among the HPS studied. Reiter’s disease has been reported 
in HIV disease among young sexually active persons. It is 
thought to be strongly linked to the sexually transmitted disease 
presence in the HIV-infected persons. It is an autoimmune 
inflammatory process directed against the joint elements 
mimicking components of infective sexually transmitted 
agents. Thus age, viral loads, CD4+ T-lymphocyte count may 
not be predictive of Reiter’s syndrome and undifferentiated 
spondyloarthropathy as seen in this study.
Logistic regression analysis was done for the HIV patients 
with HIVAA. Of the five continuous variables (VL, 
CD4+ T-lymphocyte count, age, ESR, HIV disease duration) 
entered initially, only CD4+ T-lymphocyte count was found 
to be predictive of HIV-associated arthritis.
Strengths and limitations
We could not do all possible tests to exclude possible 
confounding etiologies of articular disorders. So there was still 
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a possibility of misclassifications. There is also a possibility 
that our HIV patients presented with asymptomatic exclusion 
criteria (e.g., HIV with malignancy) then causing confusion. 
However, because we matched our test subjects and controls, 
drew the two samples also from same recruitment area, in same 
geographical and had same exclusions and inclusions criteria 
for both sub-populations, there is no reason why this possibility 
of misclassification would affect our results.
Conclusion
The study showed that articular disorders are commoner among 
HPS than HNS. HIV infection may have a significant effect 
on articular disorder development. Arthralgia was the most 
frequent articular disorder among both HPS and HNS. ESR 
and age were the best predictors of Arthralgia presence among 
HIV-infected patients. CD4+ T-cell count was predictive of 
HIV-associated arthritis.
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